Literature DB >> 10701418

A simple high-performance liquid chromatography assay for simultaneous determination of plasma norepinephrine, epinephrine, dopamine and 3,4-dihydroxyphenyl acetic acid.

Y Wang1, D S Fice, P K Yeung.   

Abstract

A reversed-phase HPLC assay coupled with electrochemical detection for simultaneously measuring plasma levels of norepinephrine, epinephrine, dopamine, and 3,4-dihydroxyphenylacetic acid (DOPAC) was developed. Separation of the catecholamines and the internal standard isoproterenol was obtained by a mobile phase consisting of 7% methanol in 0.1 M citrate buffer containing 0.3 mM sodium ethylenediaminetetraacetic acid (EDTA), and 0.5 mM 1-octanesulfonic acid, operated under isocratic condition at a flow rate of 1.2 ml/min. The potential of the guard cell was set at +650 mV, the first electrode of the analytical cell at +100 mV and the second at + 350 mV. Using a signal-to-noise ratio of > 3, the minimum detection limit assessed by direct on column injection was < 10 pg for analyte. The assays were linear from basal concentrations to 400 ng/ml. The intra- and inter-assay variations were < 10 and 15%, respectively. The assay has been applied successfully to measure plasma concentrations of these catecholamines in humans, rabbits and rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10701418     DOI: 10.1016/s0731-7085(99)00117-x

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  9 in total

1.  Autonomic activation links CNS oxygen toxicity to acute cardiogenic pulmonary injury.

Authors:  Ivan T Demchenko; S Yu Zhilyaev; A N Moskvin; Claude A Piantadosi; Barry W Allen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

2.  Nitric oxide-mediated central sympathetic excitation promotes CNS and pulmonary O₂ toxicity.

Authors:  Ivan T Demchenko; Alexander N Moskvin; Alexander I Krivchenko; Claude A Piantadosi; Barry W Allen
Journal:  J Appl Physiol (1985)       Date:  2012-03-22

3.  Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development.

Authors:  Navya Lakkappa; Praveen T Krishnamurthy; Karthik Yamjala; Sung Hee Hwang; Bruce D Hammock; B Babu
Journal:  J Pharm Biomed Anal       Date:  2017-11-16       Impact factor: 3.935

4.  Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia.

Authors:  James T Thackeray; Jerry Radziuk; Mary-Ellen Harper; Erik J Suuronen; Kathryn J Ascah; Rob S Beanlands; Jean N Dasilva
Journal:  Cardiovasc Diabetol       Date:  2011-08-10       Impact factor: 9.951

5.  Renal Denervation Promotes Atherosclerosis in Hypertensive Apolipoprotein E-Deficient Mice Infused with Angiotensin II.

Authors:  Yutang Wang; Tam N Dinh; Alexander Nield; Smriti M Krishna; Kate Denton; Jonathan Golledge
Journal:  Front Physiol       Date:  2017-04-13       Impact factor: 4.566

Review 6.  Analysis of Catecholamines and Pterins in Inborn Errors of Monoamine Neurotransmitter Metabolism-From Past to Future.

Authors:  Sabine Jung-Klawitter; Oya Kuseyri Hübschmann
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

7.  A decoupler-free simple paper microchip capillary electrophoresis device for simultaneous detection of dopamine, epinephrine and serotonin.

Authors:  Appan Roychoudhury; Kevin Antony Francis; Jay Patel; Sandeep Kumar Jha; Suddhasatwa Basu
Journal:  RSC Adv       Date:  2020-07-06       Impact factor: 4.036

8.  Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status.

Authors:  Imad Abboud; Nicolas Lerolle; Saik Urien; Jean-Marc Tadié; Françoise Leviel; Jean-Yves Fagon; Christophe Faisy
Journal:  Crit Care       Date:  2009-07-21       Impact factor: 9.097

9.  Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes.

Authors:  Ali J Chakera; Paul S Hurst; Gill Spyer; Emmanuel O Ogunnowo-Bada; William J Marsh; Christine H Riches; Chen-Yu Yueh; S Pauliina Markkula; Jeffrey W Dalley; Roger D Cox; Ian A Macdonald; Stephanie A Amiel; Kenneth M MacLeod; Lora K Heisler; Andrew T Hattersley; Mark L Evans
Journal:  Mol Metab       Date:  2018-08-13       Impact factor: 7.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.